Email Print this page Bookmark this page

FAQs

Valeant is committed to serving you. The following is a list of frequently asked questions about LACRISERT® that may not have been specifically addressed on our site:

Will my patients experience a foreign body sensation when they use LACRISERT®?
How should I advise my patient if he or she experiences transient blurring of vision?
Can LACRISERT® inadvertently be expelled from the eye?
Can I prescribe LACRISERT® if my patient is already using artificial tears or another form of Dry Eye treatment?
Can my patient sleep with LACRISERT® administered?
Can my patient use LACRISERT® while wearing contact lenses?
Is LACRISERT® visible when properly administered in the eye?
How long will LACRISERT® take to dissolve once administered in the eye?
How long will LACRISERT® last once administered in the eye?
Is LACRISERT® covered by most managed care plans?
Where can my patient fill his or her prescription for LACRISERT®?
How long will a single LACRISERT® prescription last?
Where should I report adverse events experienced by my patients while using LACRISERT®?
What if my patient has a question that was not covered here?
I am a pharmacist. How can I place an order for LACRISERT®?

Will my patients experience a foreign body sensation when they
use LACRISERT®?

If your patient is suffering from Dry Eye, he or she may already be experiencing a foreign body sensation. LACRISERT® can relieve this symptom better than artificial tears.1

Some patients do experience a foreign body sensation if LACRISERT® is misplaced. You can help your patients avoid this discomfort by instructing them on how to administer the insert properly. Allow first-time LACRISERT® users to practice a few times before leaving your office.2 These Insertion Instructions provide a simple illustration of the steps to help your patients better grasp the administration technique.

If your patient does not insert LACRISERT® properly, the insert can be removed so that a new one may be inserted. Be sure to communicate the importance of closely following the instructions for insertion or removal.

If necessary, adding a drop or more of artificial tears may help to relieve any foreign body sensation he or she might be experiencing.3

back to top

How should I advise my patient if he or she experiences transient blurring
of vision?

Transient blurring of vision is a common symptom of Dry Eye that, in many cases, can be improved with the use of LACRISERT®.2 However, LACRISERT® may also produce transient blurring of vision in certain users, generally 4 to 6 hours after insertion.1,2 This can occur due to the production of a somewhat thicker tear film than usual.4 Caution your patients against operating hazardous machinery or driving a motor vehicle while their vision is cloudy.2

You may suggest that your patient remove LACRISERT® after 3 or 4 hours until the blurriness subsides. Another LACRISERT® may be administered later, if necessary.1,2 Urge your patient to follow the instructions for insertion or removal closely.

Adding a drop or more of artificial tear products may be helpful in soothing blurred vision after inserting LACRISERT®.1,5 Wearing the inserts overnight while your sleeping can also help to relieve blurry vision as a result of LACRISERT® use.6

back to top

Can LACRISERT® inadvertently be expelled from the eye?
Yes, occasionally this can happen, especially if LACRISERT® is administered improperly or if the inferior cul-de-sac of the eye is not deep enough to keep LACRISERT® secure.2

If your patients sleep with LACRISERT® inserted, they may forget they are using LACRISERT® upon awakening and rub their eyes too hard, thereby pushing the insert out of the pocket. Advise your patients to rub their eyes gently, if necessary.2

In the case that LACRISERT® is expelled, your patient may administer another one.2

back to top

Can I prescribe LACRISERT® if my patient is already using artificial tears or another form of Dry Eye treatment?
Yes. Because LACRISERT® does not have any known drug interactions, LACRISERT® can be prescribed concomitantly with artificial tear products or other Dry Eye treatments.3,5

back to top

Can my patient sleep with LACRISERT® administered?
Yes, LACRISERT® is fully biodegradable.1 Your patient may find it comfortable allowing LACRISERT® to fully dissolve.4 However, if your patient prefers not to sleep with it, LACRISERT® can easily be removed by following the instructions for removal.

back to top

Can my patient use LACRISERT® while wearing contact lenses?
Yes. Be sure to advise your patient to put his or her contact lenses in before administering LACRISERT® to avoid the lenses getting over coated by the contents of the insert.6

back to top

Is LACRISERT® visible when properly administered in the eye?
No. LACRISERT® is a small, translucent insert that is placed out of sight, inside the inferior cul-de-sac of the eye. The contents of LACRISERT® are off-white.2

back to top

How long will LACRISERT® take to dissolve once administered in the eye?
The dissolution time for LACRISERT® may vary. However, studies show that LACRISERT® begins to dissolve comfortably within in minutes.2

back to top

How long will LACRISERT® last once administered in the eye?
In most patients, LACRISERT® provides continuous, all-day relief of symptoms. The insert lasts, on average, from 14 to 18 hours.2

back to top

Is LACRISERT® covered by most managed care plans?
Yes, LACRISERT® is covered by most managed care plans. This makes filling a prescription for LACRISERT® convenient and affordable for your patients.

Be sure to let your patients know that they can get a rebate coupon for up to $100 off their LACRISERT® prescription. Click here.

A knowledgeable representative at Valeant Patient Assistance Program can address any question your patient may have about LACRISERT® or managed care. Your patient can reach Valeant Patient Assistance directly by calling (866) 268-7325, Monday – Friday 9am-5pm (except holidays) for more information on Valeant Patient Assistance.

back to top

Where can my patient fill his or her prescription for LACRISERT®?
Valeant is committed to ensuring that supplies of LACRISERT® are available for your patient when needed. When you write a LACRISERT® prescription, your patient has the convenience of going to any local pharmacy in the United States and in many countries worldwide.

back to top

How long will a single LACRISERT® prescription last?
Each LACRISERT® prescription contains 60 inserts.2 If your patient administers LACRISERT® in each eye once daily, each prescription will cover 1 month of use.

back to top

Where should I report adverse events experienced by my patients while
using LACRISERT®?

If your patient has experienced an adverse event using LACRISERT®, contact one of our medical specialists at Valeant Pharmaceuticals Medical Affairs at (877) 361-2719.

back to top

What if my patient has a question that was not covered here?
If your patient has a question that was not covered here, you can advise your patients to contact Customer Service at Valeant Pharmaceuticals at (800) 321-4576 or by email at pharmcs@valeant.com or to contact the Valeant Patient Assistance Program at (866) 268-7325.

back to top

I am a pharmacist. How can I place an order for LACRISERT®?
LACRISERT® is available in the United States and worldwide.

All major wholesalers in the United States have LACRISERT® available:

Country Lacrisert
Product Description Pack Size NDC
Lacrisert, 5 mg 60 25010-0805-68
USA Wholesaler LACRISERT®
Item Number
Fax Phone
AmerisourceBergen 5039565 095-182 610-727-2316 952-903-7597
Bellco Drug Corp. 264495 631-841-6185 631-789-6934
Burlington Drug Company 304360 802-893-5710 802-893-5105
Capital Wholesale 196563 614-297-8224 614-297-8221
Cardinal Health 4039129 614-757-3696 614-757-5103
Dakota Drug 301713 701-857-1134 701-852-2141
Dik Drug 222-844 630-655-4031 630-655-4010
Frank W. Kerr 046-201 248-380-3627 248-349-5000
H.D. Smith Whls 2146819 217-753-1688 217-462-8299
King Drug 172569 843-662-0414 843-662-0411
Kinray, Inc. 138-586 718-767-4399 718-767-4225
McKesson 148-6521 415-983-8371 415-983-7611
McQueary Bros. 578851 417-831-5207 417-869-2577
Miami Luken, Inc. 417-618 937-743-7786 937-743-7775
Morris & Dickson Co. 829531 318-798-6007 318-797-7900
NC Mutual Wholesale Drug 495283 919-596-1453 919-596-2151
Rochester Drug Coop 90053984 585-235-6425 585-271-7220
Smith Drug Co. 25-9556 800-599-0415 800-572-1216
Valley Wholesale Drug Co. 371575 209-465-4056 209-466-0131
Value Drug Co. 897710 814-944-9553 814-944-9316

For Canada orders:

Country Lacrisert
Canada Valeant products are distributed in Canada by Valeo Pharma, Inc.
Phone: 866-694-0150
Fax: 514-694-0865

If you are a pharmacist in any other country worldwide and you would like to place an order for LACRISERT®:

Country Lacrisert
All Others Clinigen Customer Service
Tel: +1 908-927-1122 or +44 (0) 1283 494 340
Fax: +1 908 927-1123 or +44 (0) 1283 494 341
Email: NPP@valeant.com or customer.services@clinigengoup.com

back to top

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

 

sample request using Lacrisert video patient tip sheet
©2012 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC          Bridgewater, NJ 08807